Hims & Hers Health is upgraded to a speculative Buy after a 20% drop, with growth potential in GLP-1 sales outweighing key ...

Is Hims & Hers the next big player in telehealth? Our experts break down its business model, growth potential, and the risks ...

HIMS accelerates global expansion with tech-integrated care, leveraging ZAVA and semaglutide for personalized health delivery.

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Novo Nordisk’s head of U.S. marketing, Ulrich Otte, is no longer in the role and is exploring other internal opportunities at the company outside of the U.S.

Detailed price information for Science Applications International (SAIC-Q) from The Globe and Mail including charting and ...

Progressive activists in Hassan demand timely opening of super speciality hospital for improved health services.

Novo Nordisk A/S (NYSE: NVO) is one of the top oversold NYSE stocks to buy now. In a report released on August 4, Emily Field from Barclays maintained a Hold rating on Novo Nordisk A/S (NYSE:NVO), ...

One person in the clip can be heard saying that the restaurant should be shut down for allegedly forbidding people in Indian ...

Snowflake is positioned as a core enterprise platform for AI-driven data workloads. Its architecture supports deployment ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Peanut butter,cinnamon, dark chocolate chip, salted caramel ...